Source: ERJ Open Res 2016: 00100-2015
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jantina C. de Groot, Huib Storm, Marijke Amelink, Selma B. de Nijs, Edwin Eichhorn, Bennie H. Reitsma, Elisabeth H.D. Bel, Anneke ten Brinke. Clinical profile of patients with adult-onset eosinophilic asthma. ERJ Open Res 2016: 00100-2015

Member's Comments

No comment yet.

Related content which might interest you: Clinical response to mepolizumab in patients with severe eosinophilic asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Re-evaluation of asthma diagnosis in patients with adult-onset asthma Source: International Congress 2017 – New research in asthma and COPD Year: 2017 Clinical features of eosinophilic COPD Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Clinical characteristics of severe asthma subphenotypes Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Clinical features of asthmatic patients with hyperleukotrienuria Source: Eur Respir J 2002; 20: Suppl. 38, 311s Year: 2002 Benralizumab efficacy in patients with uncontrolled eosinophilic asthma by age at diagnosis Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Clinical features of steroid-resistant patients with severe steroid-dependent bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 133s Year: 2004 Incidence of allergic asthma in patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 232s Year: 2006 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Clinical features of patients with desquamative interstitial pneumonia: Association with autoimmune disorders Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Clinical and histological impact of omalizumab in oral corticosteroid-dependent severe allergic asthma Source: International Congress 2019 – Novel findings from asthma clinical trials Year: 2019 Differences between asthma–COPD overlap syndrome and adult-onset asthma Source: Eur Respir J, 49 (5) 1602383; 10.1183/13993003.02383-2016 Year: 2017 Clinical characteristics of refractory asthma Source: Eur Respir J 2003; 22: Suppl. 45, 478s Year: 2003 Virus-induced exacerbation in patients with different forms of non-allergic late-onset asthma Source: Eur Respir J 2003; 22: Suppl. 45, 516s Year: 2003 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 The allergy profile and accompanying sinonasal pathologies in patients with bronchial asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Characterisation of severe eosinophilic asthma patients who failed Mepolizumab therapy Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020